FDA approves another antibiotic for hard-to-treat skin infections
August 7th 2014FDA has approved oritavancin (Orbactiv, The Medicines Company) for injection for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
FDA approves COPD once-daily maintenance therapy
August 1st 2014FDA has approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease (COPD). The long-acting beta-adrenergic agonist (LABA) by Boehringer Ingelheim Pharmaceuticals can be used once daily as maintenance therapy.
Pharmacists at ThoughtSpot2014 committed to transform patient care
August 1st 2014Independent pharmacists will be better prepared for their new role to enhance patient care and help health plans improve their ratings under the Centers for Medicare and Medicaid (CMS) Star Rating system after attending this year’s ThoughtSpot 2014 meeting, Good Neighbor Pharmacy and AmerisourceBergen’s annual meeting in Las Vegas.